News

US judge upholds FDA's removal of Ozempic, Wegovy from drug shortage list
By Diana Novak Jones (Reuters) -A federal judge has rejected a bid by compounding pharmacies to allow them to continue making ...
The Financial Express4h
US FDA approves twice-a-year HIV shot that could end daily pills
A new HIV prevention shot, approved by the FDA and taken just twice a year, could transform global care, but experts warn ...
US FDA to shorten review time for drug developers under new voucher program
The regulator said on Tuesday that the commissioner would determine whether a company aligns with health priorities such as ...
Threat in your medicine cabinet: The FDA’s gamble on America’s drugs
The FDA didn’t routinely test the medications for quality problems or use its vast repository of drug-related complaints to proactively track whether they were harming the people who relied on them.
FoodNavigator-USA1d
FDA moves shaping US food so far in 2025
From AI-powered inspections to bold regulatory shifts on dyes and sugar, the FDA has made waves in 2025. Here are the 17 most ...
Fierce Biotech1d
FDA blocks new clinical trials that ship cells from US to China
The FDA has stopped new clinical trials that export American citizens’ living cells from the U.S. to “China and other hostile ...
We Spent a Year Investigating How the FDA Let Risky Drugs Into the U.S. Market
Our investigation exposed a little-known practice inside the FDA that allowed more than 150 drugs or their ingredients into ...
FDA says Americans' DNA sent to foreign labs in clinical trials
The U.S. Food and Drug Administration announced Thursday it halted all new clinical trials that entail sending Americans’ ...
Medscape3d
How Proposed Tariffs Could Disrupt US Drug Prices and Supply
Health policy experts say the tariffs would raise prices for patients, potentially disrupt supply, and could hurt the US ...
US FDA extends review of KalVista's swelling disorder drug due to heavy workload
KalVista Pharmaceuticals' said on Friday that the U.S. Food and Drug Administration had extended the review of its drug for a ...
U.S. News & World Report7d
US FDA Extends Review of KalVista's Swelling Disorder Drug Due to Heavy Workload
US FDA Extends Review of KalVista's Swelling Disorder Drug Due to Heavy Workload By Puyaan Singh (Reuters) -KalVista Pharmaceuticals' said on Friday that the U.S. Food and Drug Administration had ...